Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes : A meta-analysis of pivotal trials

Publié dans Platelets 2017 Mar;28(2):174-181 Auteurs : Roule V, Agueznai M, Sabatier R, Blanchart K, Lemaitre A, Ardouin P, Collet JP, Milliez P, Montalescot G, Beygui F. Article disponible en consultant le site Abstract The risk and benefit of GP-IIb/IIIa Inhibition (GPI) in combination with recent antiplatelet regimens in acute coronary syndromes (ACS) remain unassessed.…